There is great value in reviewing the road an organization has travelled to get it to the place it is today. Accordingly, the process of identifying where you have been is both a qualitative and quantitative process. This study will analyse the background of the company and determine in detail the internal resources.
Table of Contents
I. Introduction
II. Company Background
2.1 Current Performance and Results
2.1.1 Results 1998-2003
2.1.2 Key financial developments in 2003 (nine month results) vs. 2002
2.2. Strategic Posture
2.2.1. Mission
2.2.2 Objectives and Strategies
III. Internal Scanning
3.1 Structure analysis: Corporate structure
3.2 Culture analysis: Corporate culture
3.3 Internal Analysis of Resources and Functions
3.3.1. Internal Resource Analysis
3.3.1.1. Financial Resources
3.3.1.2. Human Resources
3.3.1.3. Intangible Resources: Knowledge Networking
4.3.2 Analysis of functional areas
3.3.2.1. Marketing
3.3.2.2. Research and Development
3.4 Competitive advantages of Novartis
IV. Conclusion
V. Bibliography
Objectives and Topics
This study aims to provide a comprehensive internal analysis of Novartis, focusing on its organizational background, resource allocation, and strategic direction to evaluate its competitive positioning within the global pharmaceutical industry.
- Analysis of corporate performance and financial developments
- Evaluation of mission, corporate objectives, and growth strategies
- Assessment of organizational structure and corporate culture
- Examination of internal resources including financial, human, and intangible assets
- Deep dive into functional areas such as marketing and R&D
Excerpt from the Book
3.1 Structure analysis: Corporate structure
Structure defines the patterns of relationships within an organization and is crucial in effective strategy implementation (Moran, 2003).
Novartis is a matrix organization titled in power towards line management (Nayman, 2003). The matrix structure combines the stability of the functional structure with the flexibility of the product form. The matrix structure is advantageously for Novartis when facing its fast changeable external environment. But a matrix structure also involves an additional set of management positions, which can increase overhead costs and bureaucracy and affect optimal organization as companies globalise (Baron and Besanko, 1996).
The Novartis Group is divided operationally on a worldwide basis into the divisions Pharmaceuticals and Consumer Health that incorporate several business units.
Summary of Chapters
I. Introduction: Outlines the purpose of the study as a qualitative and quantitative analysis of the company's background and internal resources.
II. Company Background: Details the formation of Novartis through a 1996 merger and describes its primary business divisions and regional footprint.
III. Internal Scanning: Analyzes the company's matrix organizational structure, the shift towards a result-driven corporate culture, and the utilization of financial, human, and knowledge-based resources.
IV. Conclusion: Summarizes the impact of R&D and culture on performance while highlighting the challenge of relying on the mature European market.
Keywords
Novartis, Pharmaceutical Industry, Strategic Management, Internal Analysis, Corporate Structure, Corporate Culture, Financial Resources, Human Resources, Knowledge Networking, R&D, Marketing, Market Penetration, Competitive Advantage, Growth Strategy, Healthcare Sector
Frequently Asked Questions
What is the core focus of this publication?
The work provides an internal scan of the pharmaceutical company Novartis, evaluating how its internal resources, structure, and culture contribute to its strategic goals.
Which primary themes are covered in the analysis?
The analysis covers financial performance, corporate mission and objectives, organizational structure, internal resource management, and specialized functions like R&D and marketing.
What is the ultimate goal of the research?
The study aims to identify internal strategic factors and evaluate how they support Novartis in achieving sustainable growth and a competitive advantage.
Which methodology is applied to the research?
The report uses an internal analysis approach, combining qualitative assessments of strategy and culture with quantitative reviews of financial data and human resource metrics.
What topics does the main body explore?
The main body examines the company's background, financial history, matrix structure, leadership style, workforce management, and the effectiveness of its research and development pipeline.
Which keywords define this work?
Key terms include pharmaceutical industry, strategic management, corporate structure, R&D, financial resources, and competitive advantage.
How has the corporate culture at Novartis evolved?
Following the 1996 merger, Novartis moved from the autocratic, hierarchical roots of its predecessors toward a dynamic, result-driven culture promoted by CEO Daniel Vasella.
What role do research and development play at Novartis?
R&D is the cornerstone of Novartis' competitive strategy, characterized by high investment levels and a focus on reducing development cycle times to bring innovative treatments to market faster.
Why does the report consider Novartis' reliance on the European market a weakness?
The European pharmaceutical market is described as mature with lower growth potential, necessitating expansion into higher-growth regions to ensure long-term sustainability.
- Quote paper
- Fatma Torun (Author), 2004, Novartis – an internal scanning of a pharmaceutical company, Munich, GRIN Verlag, https://www.grin.com/document/37239
